Literature DB >> 22310229

Structure-activity relationship study of selective benzimidazole-based inhibitors of Cryptosporidium parvum IMPDH.

Sivapriya Kirubakaran1, Suresh Kumar Gorla, Lisa Sharling, Minjia Zhang, Xiaoping Liu, Soumya S Ray, Iain S Macpherson, Boris Striepen, Lizbeth Hedstrom, Gregory D Cuny.   

Abstract

Cryptosporidium parasites are important waterborne pathogens of both humans and animals. The Cryptosporidium parvum and Cryptosporidium hominis genomes indicate that the only route to guanine nucleotides is via inosine 5'-monophosphate dehydrogenase (IMPDH). Thus the inhibition of the parasite IMPDH presents a potential strategy for treating Cryptosporidium infections. A selective benzimidazole-based inhibitor of C. parvum IMPDH (CpIMPDH) was previously identified in a high throughput screen. Here we report a structure-activity relationship study of benzimidazole-based compounds that resulted in potent and selective inhibitors of CpIMPDH. Several compounds display potent antiparasitic activity in vitro.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22310229      PMCID: PMC3289519          DOI: 10.1016/j.bmcl.2012.01.029

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  14 in total

1.  Cyclosporin analogs inhibit in vitro growth of Cryptosporidium parvum.

Authors:  M E Perkins; T W Wu; S M Le Blancq
Journal:  Antimicrob Agents Chemother       Date:  1998-04       Impact factor: 5.191

Review 2.  An updated review on Cryptosporidium and Giardia.

Authors:  David B Huang; A Clinton White
Journal:  Gastroenterol Clin North Am       Date:  2006-06       Impact factor: 3.806

3.  Genetic complementation in apicomplexan parasites.

Authors:  Boris Striepen; Michael W White; Catherine Li; Michael N Guerini; S-Banoo Malik; John M Logsdon; Chang Liu; Mitchell S Abrahamsen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

Review 4.  Cryptosporidium: a water-borne zoonotic parasite.

Authors:  Ronald Fayer
Journal:  Vet Parasitol       Date:  2004-12-09       Impact factor: 2.738

5.  The genome of Cryptosporidium hominis.

Authors:  Ping Xu; Giovanni Widmer; Yingping Wang; Luiz S Ozaki; Joao M Alves; Myrna G Serrano; Daniela Puiu; Patricio Manque; Donna Akiyoshi; Aaron J Mackey; William R Pearson; Paul H Dear; Alan T Bankier; Darrell L Peterson; Mitchell S Abrahamsen; Vivek Kapur; Saul Tzipori; Gregory A Buck
Journal:  Nature       Date:  2004-10-28       Impact factor: 49.962

6.  Gene transfer in the evolution of parasite nucleotide biosynthesis.

Authors:  Boris Striepen; Andrea J P Pruijssers; Jinling Huang; Catherine Li; Marc-Jan Gubbels; Nwakaso N Umejiego; Lizbeth Hedstrom; Jessica C Kissinger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

7.  Cryptosporidium parvum IMP dehydrogenase: identification of functional, structural, and dynamic properties that can be exploited for drug design.

Authors:  Nwakaso N Umejiego; Catherine Li; Thomas Riera; Lizbeth Hedstrom; Boris Striepen
Journal:  J Biol Chem       Date:  2004-07-21       Impact factor: 5.157

8.  Complete genome sequence of the apicomplexan, Cryptosporidium parvum.

Authors:  Mitchell S Abrahamsen; Thomas J Templeton; Shinichiro Enomoto; Juan E Abrahante; Guan Zhu; Cheryl A Lancto; Mingqi Deng; Chang Liu; Giovanni Widmer; Saul Tzipori; Gregory A Buck; Ping Xu; Alan T Bankier; Paul H Dear; Bernard A Konfortov; Helen F Spriggs; Lakshminarayan Iyer; Vivek Anantharaman; L Aravind; Vivek Kapur
Journal:  Science       Date:  2004-03-25       Impact factor: 47.728

9.  Development of a microtitre ELISA to quantify development of Cryptosporidium parvum in vitro.

Authors:  K M Woods; M V Nesterenko; S J Upton
Journal:  FEMS Microbiol Lett       Date:  1995-04-15       Impact factor: 2.742

10.  A screening pipeline for antiparasitic agents targeting cryptosporidium inosine monophosphate dehydrogenase.

Authors:  Lisa Sharling; Xiaoping Liu; Deviprasad R Gollapalli; Sushil K Maurya; Lizbeth Hedstrom; Boris Striepen
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10
View more
  27 in total

1.  Validation of IMP dehydrogenase inhibitors in a mouse model of cryptosporidiosis.

Authors:  Suresh Kumar Gorla; Nina N McNair; Guangyi Yang; Song Gao; Ming Hu; Venkatakrishna R Jala; Bodduluri Haribabu; Boris Striepen; Gregory D Cuny; Jan R Mead; Lizbeth Hedstrom
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

2.  Benzoxazoles, Phthalazinones, and Arylurea-Based Compounds with IMP Dehydrogenase-Independent Antibacterial Activity against Francisella tularensis.

Authors:  Suresh Kumar Gorla; Yan Zhang; Meaghan M Rabideau; Aiping Qin; Shibin Chacko; Amanda L House; Corey R Johnson; Kavitha Mandapati; Hannah M Bernstein; Elizabeth S McKenney; Helena Boshoff; Minjia Zhang; Ian J Glomski; Joanna B Goldberg; Gregory D Cuny; Barbara J Mann; Lizbeth Hedstrom
Journal:  Antimicrob Agents Chemother       Date:  2017-09-22       Impact factor: 5.191

Review 3.  Inhibitors of inosine 5'-monophosphate dehydrogenase as emerging new generation antimicrobial agents.

Authors:  Kapil Juvale; Althaf Shaik; Sivapriya Kirubakaran
Journal:  Medchemcomm       Date:  2019-05-02       Impact factor: 3.597

4.  Repurposing cryptosporidium inosine 5'-monophosphate dehydrogenase inhibitors as potential antibacterial agents.

Authors:  Kavitha Mandapati; Suresh Kumar Gorla; Amanda L House; Elizabeth S McKenney; Minjia Zhang; Suraj Nagendra Rao; Deviprasad R Gollapalli; Barbara J Mann; Joanna B Goldberg; Gregory D Cuny; Ian J Glomski; Lizbeth Hedstrom
Journal:  ACS Med Chem Lett       Date:  2014-06-10       Impact factor: 4.345

5.  Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA.

Authors:  Fardokht A Abulwerdi; Matthew D Shortridge; Joanna Sztuba-Solinska; Robert Wilson; Stuart F J Le Grice; Gabriele Varani; John S Schneekloth
Journal:  J Med Chem       Date:  2016-12-02       Impact factor: 7.446

6.  A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenase.

Authors:  Kehinde F Omolabi; Emmanuel A Iwuchukwu; Clement Agoni; Fisayo A Olotu; Mahmoud E S Soliman
Journal:  J Mol Model       Date:  2021-01-09       Impact factor: 1.810

Review 7.  A review of the global burden, novel diagnostics, therapeutics, and vaccine targets for cryptosporidium.

Authors:  William Checkley; A Clinton White; Devan Jaganath; Michael J Arrowood; Rachel M Chalmers; Xian-Ming Chen; Ronald Fayer; Jeffrey K Griffiths; Richard L Guerrant; Lizbeth Hedstrom; Christopher D Huston; Karen L Kotloff; Gagandeep Kang; Jan R Mead; Mark Miller; William A Petri; Jeffrey W Priest; David S Roos; Boris Striepen; R C Andrew Thompson; Honorine D Ward; Wesley A Van Voorhis; Lihua Xiao; Guan Zhu; Eric R Houpt
Journal:  Lancet Infect Dis       Date:  2014-09-29       Impact factor: 25.071

8.  Phthalazinone inhibitors of inosine-5'-monophosphate dehydrogenase from Cryptosporidium parvum.

Authors:  Corey R Johnson; Suresh Kumar Gorla; Mandapati Kavitha; Minjia Zhang; Xiaoping Liu; Boris Striepen; Jan R Mead; Gregory D Cuny; Lizbeth Hedstrom
Journal:  Bioorg Med Chem Lett       Date:  2012-12-27       Impact factor: 2.823

9.  Inhibition of Inosine-5'-monophosphate Dehydrogenase from Bacillus anthracis: Mechanism Revealed by Pre-Steady-State Kinetics.

Authors:  Yang Wei; Petr Kuzmič; Runhan Yu; Gyan Modi; Lizbeth Hedstrom
Journal:  Biochemistry       Date:  2016-09-02       Impact factor: 3.162

10.  Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.

Authors:  Suresh Kumar Gorla; Mandapati Kavitha; Minjia Zhang; James En Wai Chin; Xiaoping Liu; Boris Striepen; Magdalena Makowska-Grzyska; Youngchang Kim; Andrzej Joachimiak; Lizbeth Hedstrom; Gregory D Cuny
Journal:  J Med Chem       Date:  2013-05-13       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.